Yıldız, F.; Öksüzoğlu, B. Efficacy and Toxicity of Everolimus Plus Exemestane in Third and Later Lines Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer. J Surg Med 2020, 4, 443-446.